---
title: "Hangzhou Bangshun Pharmaceutical submitted an IPO application for the Hong Kong stock market"
description: "Hangzhou Bangshun Pharmaceutical submitted an IPO application for the Hong Kong stock market"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/273353551.md"
published_at: "2026-01-22T10:01:09.000Z"
---

# Hangzhou Bangshun Pharmaceutical submitted an IPO application for the Hong Kong stock market

Hangzhou Bangshun Pharmaceutical submitted a Hong Kong stock IPO application

### Related Stocks

- [25346.HK - 杭州高光制药股份有限公司](https://longbridge.com/en/quote/25346.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 2 dividend stocks to double up on right now | These pipeline stocks offer generous investment income, with room to grow those payouts even more. | [Link](https://longbridge.com/en/news/276375009.md) |
| 11:58 ETBio Decontamination Market to Reach $525.4 million by 2033 Globally, at 8.7% CAGR: Allied Market Research | Allied Market Research reports that the global bio decontamination market is projected to grow from $229.5 million in 20 | [Link](https://longbridge.com/en/news/276360178.md) |
| 08:15 ETRoviSys Advances Regulated Industry Facilities Strategy, Names Chris Kulbago Director | RoviSys has promoted Chris Kulbago to Director of Building Technologies, focusing on pharmaceutical, biotech, and food a | [Link](https://longbridge.com/en/news/276232217.md) |
| Gedik Says It Is To Propose Ending Its Share Buyback Program | GEDİK YATIRIM MENKUL DEĞERLER :SAID ON TUESDAY, IT IS TO PROPOSE ENDING ITS SHARE BUYBACK PROGRAM AUTHORIZED ON JANUARY  | [Link](https://longbridge.com/en/news/276200195.md) |
| Quantum eMotion to Commence Trading on NYSE American Under the Ticker "QNC" \| QNC Stock News | Quantum eMotion Corp. has received approval to list its common shares on NYSE American under the ticker "QNC," with trad | [Link](https://longbridge.com/en/news/276340435.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.